logo-loader

Bitcoin-backed recruiter Connecting Excellence completes first acquisition

Published: 17:24 05 Oct 2026 AEDT

Connecting Excellence Group Plc - Bitcoin-backed recruiter Connecting Excellence completes first acquisition

Connecting Excellence Group Plc (AQSE:XCE, OTCQB:XCELF), the recruitment company that holds Bitcoin as a long-term reserve, has completed its first acquisition by buying James Gray Recruitment.

The deal also takes in James Gray Engineering and adds £1.79 million of revenue, up 21.5%, in the 12 months to 30 June.

Earnings before interest, tax, depreciation and amortisation (EBITDA) for the two businesses combined were £431,000, on gross profit of £1.27 million.

James Gray is a specialist construction and engineering recruiter placing technical, management and leadership candidates in the UK, US and internationally.

The upfront cash is £575,000, but about £425,000 was settled by offsetting sums owed. That leaves a net cash outflow of about £150,000 on completion, before transaction costs.

The rest of the price is deferred and depends on EBITDA delivered in 2027, 2028 and 2029, with nothing payable below a minimum threshold.

Connecting Excellence expects to keep 75% to 85% of cumulative EBITDA over the earn-out period.

Bitcoin holding rises

The businesses also held 8.216 Bitcoin, worth £531,223, which the group paid for from a £600,000 share subscription.

Its total holding rises to 81.157 Bitcoin, valued at £5.25 million.

The company has also arranged a revolving credit facility with BitGo, its Bitcoin custodian, allowing drawings of up to $1.5 million.

Chief executive Scott Ellam says this is the first of a series of potential deals in an identified pipeline.

He points to up to 1,000 owner-managed recruiters in the UK and around 10,000 worldwide.

XanaMIA results: What's next for Actinogen Medical?

Actinogen Medical Ltd CEO Dr Steven Gourlay talked with Proactive about the topline results from the company's XanaMIA clinical trial, which evaluated its investigational Alzheimer's disease treatment Xanamem. The study revealed encouraging signs of disease slowing in patients aged...

9 hours, 44 minutes ago